This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Technische Universitat Dortmund. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Jörn Weisner: Innovator in Cancer Therapy
Introduction
Jörn Weisner is a notable inventor based in Herten, Germany. He has made significant contributions to the field of cancer therapy through his innovative research and development of kinase inhibitors. His work is pivotal in advancing treatment options for cancer patients.
Latest Patents
Weisner holds a patent for "Kinase inhibitors and their use in cancer therapy." This invention relates to a 2,3-diphenyl-1,6-naphthyridine-5-one derivative, which is utilized in the diagnosis or treatment of cancer. The patent highlights the potential of this derivative in improving therapeutic outcomes for patients.
Career Highlights
Jörn Weisner is affiliated with Technische Universität Dortmund, where he engages in cutting-edge research. His academic background and expertise in medicinal chemistry have positioned him as a key figure in the development of cancer therapies.
Collaborations
Throughout his career, Weisner has collaborated with esteemed colleagues, including Daniel Rauh and Rajesh Gontla. These partnerships have fostered a collaborative environment that enhances the research and development of innovative cancer treatments.
Conclusion
Jörn Weisner's contributions to cancer therapy through his patented innovations demonstrate his commitment to improving patient care. His work continues to inspire advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile